STAGE II TO III (T1CN1-2 OR T2-4N0-2) TNBC BREAST CANCER

Clinical trials for STAGE II TO III (T1CN1-2 OR T2-4N0-2) TNBC BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new STAGE II TO III (T1CN1-2 OR T2-4N0-2) TNBC BREAST CANCER trials appear

Sign up with your email to follow new studies for STAGE II TO III (T1CN1-2 OR T2-4N0-2) TNBC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Double-Drug attack on aggressive breast cancer before surgery

Disease control Not yet recruiting

This study tests whether combining two drugs (SKB264 and pembrolizumab) given before surgery can eliminate cancer cells in patients with stage II-III triple-negative breast cancer. The trial will enroll 52 patients who haven't had previous cancer treatment to see if this combinat…

Matched conditions: STAGE II TO III (T1CN1-2 OR T2-4N0-2) TNBC BREAST CANCER

Phase: PHASE2 • Sponsor: Yantai Yuhuangding Hospital • Aim: Disease control

Last updated Mar 18, 2026 14:41 UTC

STAGE II TO III (T1CN1-2 OR T2-4N0-2) TNBC BREAST CANCER

Get alerted when new STAGE II TO III (T1CN1-2 OR T2-4N0-2) TNBC BREAST CANCER trials appear

Double-Drug attack on aggressive breast cancer before surgery